title: Fluoxetine 40 mg vs maprotiline 75 mg in the treatment of out-patients with depressive disorders.
authors.affiliation: Psychiatrische Univ. Klinik Basel, Switzerland.
authors.forename: W
authors.initials: W
authors.lastname: Poelinger
authors.forename: H
authors.initials: H
authors.lastname: Haber
mesh_terms: D000328:Adult; D000368:Aged; D000873:Anthracenes / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003866:Depressive Disorder / Q000188:drug therapy*; D004311:Double-Blind Method; D005260:Female; D005473:Fluoxetine / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008376:Maprotiline / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales
chemical_list: D000873:Anthracenes; D005473:Fluoxetine; D008376:Maprotiline